Rare diseases
Investigational molecules
Locations
Carrer De San Quinti 89, 08041 Barcelona, Spain
Hospital De La Santa Creu I Sant Pau in Barcelona, Spain specialises in clinical trials of conditions such as Non-small cell lung cancer, Dementia Alzheimer's type, Acute myeloid leukaemia, Non-small cell lung cancer metastatic, and other specialisations. This site conducts important research.
The Hospital De La Santa Creu I Sant Pau conducts cutting‑edge research on neoplasms, focusing on solid tumors and hematologic malignancies across the Barcelona region.
A total of 13 clinical trials involve 186 investigators, advancing therapeutic options for cancer patients.
Within the department of Neurology, the site explores treatments for neurodegenerative and headache disorders, aiming to improve quality of life for affected individuals.
Ongoing studies leverage the expertise of 186 investigators to evaluate efficacy and safety in the nervous system field.
Research in immune system diseases targets autoimmune skin conditions, employing innovative immunomodulatory approaches to reduce disease burden.
The department’s 13 trials aim to expand therapeutic options for patients with challenging immune‑mediated disorders.
The site’s work on respiratory tract diseases integrates oncology and pulmonary health, seeking to improve outcomes for lung‑related malignancies.
Clinical investigations combine oncology expertise with respiratory assessments to refine treatment strategies.
Studies in digestive system diseases concentrate on colorectal cancer, exploring targeted regimens that enable curative surgical interventions.
These trials contribute to multidisciplinary care pathways for patients with gastrointestinal malignancies.
The department supports investigations into congenital and hereditary conditions, emphasizing early detection and genetic counseling to guide preventive strategies.
Collaborative efforts with genetics specialists aim to integrate precision medicine from birth onward.
Research on circulatory and respiratory physiological phenomena underpins many therapeutic trials, providing biomarkers that inform treatment response.
These physiological insights enhance the safety and effectiveness of interventions across multiple disease areas.
Clinical trials currently enrolling participants at this site.
Study of Brenipatide (LY3537031) in Adults with Major Depressive Disorder to Evaluate Delay of Relapse Compared with Placebo
SpainPhase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
SpainLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
SpainBI 3000202 in Patients with Moderate to Severe Systemic Lupus Erythematosus
SpainA study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer
SpainStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
SpainA Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
SpainA Study Testing How Well Bimekizumab Works and How Safe It Is for Adults with Palmoplantar Pustulosis
SpainStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
SpainA study comparing dotinurad and allopurinol for lowering uric acid levels in adults with gout and high uric acid in the blood.
SpainStudy of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
SpainStudy of GSK5764227 alone and in combination for patients with previously treated advanced gastrointestinal tumors that cannot be removed by surgery or have spread
SpainMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
